Avrobio Inc Reports Results For The Quarter Ended In June: Earnings Summary

Tectonic Therapeutic

09/08/2022 15:56

* AVROBIO Inc  AVRO.OQ  reported a quarterly adjusted loss
of 64
cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 57 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * AVROBIO Inc's reported EPS for the quarter was a loss
of 64
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AVROBIO Inc shares had risen by 9.8% this quarter and
lost 73.8%
so far this year.
    * The company reported a quarterly loss of $28.05 million.
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 02:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.57          -0.64          Missed
 Mar. 31 2022      -0.59          -0.68          Missed
 Dec. 31 2021      -0.74          -0.65          Beat
 Sep. 30 2021      -0.76          -0.75          Beat